Today, the FDA approved an updated label for a treatment option for adults living with pulmonary arterial hypertension (#PAH).
Read more: go.merck.com/~c9i
00:00
Merck
@Merck
We aspire to be the premier research-intensive biopharmaceutical company. Intended for U.S. residents only.
FLS: merck.us/3TKXNuZ
